Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 19, 2023, titled "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Press Release on the Audited Financial Results of the Company for the quarter and year ended March 31, 2023.".